ArticleThe Journal of clinical investigation2019

Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.

Dhanya K Nambiar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.